Susquehanna Fundamental Investments, LLC Fulcrum Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.26 - $3.8 $42,804 - $71,972	-18,940 Reduced 45.6%	22,594 $74,000
Q1 2023 May 16, 2023	SELL	$2.83 - $13.99 $121,757 - $601,905	-43,024 Reduced 50.88%	41,534 $118,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $134,057 - $223,429	26,758 Added 46.29%	84,558 $615,000
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $284,376 - $525,980	57,800 New	57,800 $468,000
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $808,164 - $1.64 Million	-57,726 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $420,245 - $1.79 Million	57,726 New	57,726 $1.63 Million

149

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $227M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.